Methods for Assessing Improvement in Specificity when a Biomarker is Combined with a Standard Screening Test

Pamela A Shaw1, Margaret S Pepe, Todd A Alonzo

  • 1Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.

Summary

New methods evaluate combination diagnostic tests using relative true and false positive rates. This approach enhances specificity for screening tests, reducing false positives in biomarker discovery for diseases like breast and prostate cancer.